Submit Ideas
--Must See--

Submit Ideas To Fight COVID-19 : C-CAMP COVID-19 Innovations Deployment Accelerator

Submit Ideas To Fight COVID-19. Interested and eligible applicants can check out all of the details on the same below:

COVID-19 outbreak has wreaked havoc across the world with ramifications poised to surpass any catastrophe in our living memory. We believe that the fightback will start with your out-of-the-box innovative solutions and our ecosystem to change the course of this raging pandemic.

C-CAMP has launched C-CAMP COVID-19 Innovations Deployment Accelerator or CCIDA on 26th March 2020 to help accelerate COVID-19 innovations stuck in last-mile issues. The initiative by C-CAMP has now been joined by multiple partners:- UNHIE, Social Alpha, XYNTEO India2022, MedTechConnect, India Health Fund, AIC CCMB and CCMB.

CCIDA has announced a search for innovations that are ready to be deployed immediately or in the near future to curb the COVID-19 outbreak.

Based on the assessment, we will help in:

  • fast-tracking promising innovations for pilot deploymentscaling through industry partnership, navigating regulatory pathway and connecting with investors.
  • Selected innovations will get fast track technology assessment or HTA and an opportunity to get scale-up investment and implementation as facilitated by the United Nations Health Innovation Exchange or UNHIE.
  • Support in industrial/manufacturing opportunities through India2022 and MedTechConnect networks.
  • Opportunity to raise funding from India2022 partners.

The assessment criteria will include readiness

for deployment, scientific validity, feasibility, and impact. Assessment will happen daily. In the next few days, we will select and help most impactful innovations that are quickest to deploy. 

Innovations can be under following categories: screening, diagnostics, therapeutics, vaccines, containment strategies, public health & other categories including but not limited to focussed technologies in

  • mobile health technologies for screening and homecare,
  • diagnostic kits and Point of Care tests,
  • protective gear and sterilization innovations for care providers,
  • digital triaging tools and risk stratifying systems,
  • low-cost ventilators and oxygen therapy units,
  • AI systems to assist critical care,
  • supply chain innovations,
  • volunteerism and service innovations and
  • scalable plug and play isolation units, treatment tents

Submit an executive summary of your innovation here

Confidentiality commitment: Information submitted using this form will be treated as strictly confidential; however, if you have any specific IP related concerns, kindly share non-confidential information only.

For more information, please write to: [email protected].

CCIDA Partners: 

About C-CAMP Centre for Cellular and Molecular Platforms (C-CAMP): C-CAMP is a member of the Bangalore Life Sciences Cluster (BLiSC) with a mandate to enable cutting-edge life science research and innovation, and promote life science entrepreneurship. It is India’s premier innovation and technology hub as well as one of the largest and most thriving life sciences incubators in the country. C-CAMP has directly funded, incubated and mentored close to 150 start-ups over the last few years and is connected to about 1000 startups and entrepreneurs across the country in healthcare, agriculture and environment. C-CAMP is an initiative supported by Department of Biotechnology, Ministry of Science and Technology, and NITI Aayog, GoI. Find more details on

About UN Health Innovation Exchange: UNHIE is a new initiative by UNAIDS and partners to leverage the potential of innovations to improve the health of all. The Health Innovation Exchange will link innovators to investors and innovations to implementers. Launched on the sidelines of the World Health Assembly in Geneva, Switzerland, the initiative aims to support global efforts to reach the Sustainable Development Goals. To respond to demands from countries, over the coming months UNAIDS will facilitate country-level innovation exchanges in key countries. Those exchanges will identify specific health-related challenges and areas in which innovation and technology could transform access to health care. For more details please visit:

About Social Alpha: Social Alpha promotes innovations and entrepreneurship with a mission to create large scale social, economic and environmental impact. Social Alpha nurtures start-ups through their lab to market journey, helping them create high quality, commercially viable, accessible and affordable solutions. Foundation for Innovation and Social Entrepreneurship (FISE) forms the core of the Social Alpha architecture and operates through a nationwide network of technology and business incubation infrastructure sponsored and enabled by Tata Trusts, Government of India and several academic, philanthropic and corporate partnerships. Social Alpha is focused on catalysing entrepreneurship for impact and provides critical technology and business incubation support to the mission-driven start-ups. For more information, please visit

About Xynteo: Xynteo is an advisory firm working with global companies to identify and carry out projects enabling our mission of reinventing growth. India2022, powered by Xynteo, is a purpose-driven global coalition committed to creating proof points for a new model of growth by 2022, the 75th year of India’s independence. The Aditya Birla Group, Hindustan Unilever, Shell, TechnipFMC, Baker Hughes, WPP, State Bank of India, Cyient and Tata Trusts have committed to this bold goal and are the current partners of the India2022 coalition. The coalition was launched in March 2017 with blessings from the then President of India, Shri Pranab Mukherjee who praised this initiative as “the need of the hour”. Currently, India2022 partners are working to develop projects across four impact tracks including Energise, Waste and Sanitation, Healthcare and Sustainable Mining

About MedTechConnect: MedTechConnect platform is designed to strengthen the ecosystem in India by bringing together innovative healthcare solutions, disruptive delivery models, and pioneering funding models to make critical medical technologies accessible to everyone. India is home to a thriving technology ecosystem, yet more than 80% of its medical technologies are imported. A large segment of the country’s population still does not have access to basic healthcare services. To combat these challenges, Cyient and India2022 (powered by Xynteo) have partnered to build MedTechConnect, a platform that brings all Medtech stakeholders together to address India’s ‘last-mile challenge’ in healthcare and touch 10 million lives by 2022

About AIC-CCMB: Atal Incubation Centre – Centre for Cellular & Molecular Biology (AIC-CCMB) is an incubator dedicated to providing a thriving ecosystem for start-ups and scientists with early-stage technologies in life sciences through funding opportunities, latest biologics equipment, mentorships and financial advice. A place where innovators and start-ups in Healthcare, Pharmaceuticals and Biotechnology can find business support services and a hand holding network necessary to take their idea to the next level. With a history of successful home-grown enterprises, CSIR – CCMB has always fostered the spirit of entrepreneurship. We are sowing the capital of our combined knowledge of scientific research, product development, and business development to help startups succeed. We harness our insight, experience, and expertise in helping entrepreneurs to achieve their goals. It is our aim to transform scientific research into successful start-ups that can help alleviate the quality of life of the general population and mitigate some of the world’s biggest challenges in healthcare, food and animal care. Innovations in life sciences are critical to “Make in India” specifically to improve the quality of life of the general population. At AIC-CCMB, we endeavour to build an ecosystem to enable biotechnology innovation. As Indian researchers and innovators begin to expand the boundaries of science, pursuing novel therapies, diagnostics, medical devices and industrial solutions, we want to ensure that their technologies are translated into sustainable business solutions that reach the citizens.

About CCMBCentre for Cellular and Molecular Biology under the Council of Scientific & Industrial Research (CSIR) is a premier research organization engaged future-forward areas of modern biology. The Centre conducts high-quality basic research and training in modern biology and promotes centralized national facilities for new and modern techniques in the inter-disciplinary areas of biology. Its mission is to conduct research in frontier and multi-disciplinary areas of modern biology and to seek potential applications of this work. CSIR -CCMB has the mandate to train people in the advanced areas of biology to serve the needs of development in these areas, with special provision for short-term training of staff from other institutions in techniques for which adequate facilities may not exist elsewhere. This centre provides centralized facilities in the country for new and modern techniques in the inter-disciplinary areas of biology, and to ensure that these facilities are so organized, maintained and administered that they can be put to maximal use by research workers from other laboratories and institutions in the country.

About India Health FundThe India Health Fund (IHF) was set up by Tata Trusts in strategic partnership with The Global Fund. The Trusts seeded the IHF with an initial corpus of US$ 15 million, with a target of raising an additional US$ 135 million over the next five years to invest in innovations to eliminate TB, Malaria and other infectious diseases in India. The Fund’s primary goal is to aggregate resources towards fostering innovations to accelerate progress towards elimination of Tuberculosis (TB) by 2025 and Malaria by 2030, by enabling their lab to the last-mile journey.

View Notification

Editor’s Note: Submit Ideas To Fight COVID-19 C-CAMP. C-CAMP Submit Ideas To Fight COVID-19. Latest C-CAMP Submit Ideas To Fight COVID-19. Submit Ideas To Fight COVID-19 : C-CAMP COVID-19 Innovations Deployment Accelerator. Please make sure that you are subscribed to the Biotecnika Times Newsletter and our YouTube channel to be notified of all of the latest in the industry. Follow us on all of our social media like Twitter, Facebook and Instagram.

Upload your CV to Biotecnika

Diligence + Intelligence + Learned +Understanding +Xenial + Idealistic = DILUXI. Girl with the golden hands, She has worked hard and transformed BioTecNika's Alerts section with Latest Notifications and Articles with most profound insights. When we need a reliable hand at work, All eyes turn to her!


  1. 1=We need some binding agents ,which bind with virus and make it to not interact with other cell like cages…
    2=And another one is if we break the life cycle of virus by changing ph .
    3= May be the trapping and killing the virus is easy so it stops infecting other health cells ..

    May be my small idea helpful for the fighting against covid 19.

  2. We can try out some modified Sequences that attach to only RNA of infectious virus stop the life process or denature its infectious property by forming double standard. So, automatically its life process or infectious property will end .

  3. Specific antibodies ( monoclonal abs) against covid 19 from revoverd patients or using some siddha medicine compounds to for delete that viruses by stimulating our immune system or antiviral drugs of another saars family virus may be blocking covid 19 .

  4. If we able to find out genome sequence of covid 19. we can prepare an DNA or RNA vaccine which bind to particular viral sequence so that we can stop the viral genome to be replicate.

  5. Sir actually our researcher do their level best still they are unable to produce antibiotics or vaccine..if they share their problems in social media this problem can be we know that in india there are several mbbs students msc students PhD candidate etc which may have any idea related to their problems..

  6. Can we used anti sense RNA technology for blocking ,replication of viruse or particular genome sequence which is act as antigens??

  7. Can we used anti sense RNA technology for blocking ,the replication of viruse or particular genome sequence (antigen sequence)??

  8. Use Eyurvedic cada ginger , tulsi ,termeric black ,lounge ,pepper, piper, lemon day in 10 time use with hot water

  9. Virus replication stop Karna padega.. lac opron ke throug Jo chies use multiple honi se rok saki usko use Karna chaheye… & Konsa factor use multiple honi Mai help kartha hai o Bhi pata Karna chaheye

  10. What if this viruse lives in the air as well as in people. Could some safe spray be found to wipe it out using aircraft and ground units

  11. Drug repurposing and combination drug treatment with good immune boosters would help to some extent to control the disease.

  12. If the corona virus is not able to live at high temperatures. Then we can give a hot water steam bath to the patients who are infected with covid 19,such that the cell membranes of corona can get ruptured and we can tolerate high temperatures. If it’s possible.then we can use this method.

  13. #Gopi chelasani
    No, covid-19 can’t be killed by hot steam bath because human body regulates body temprature if you continue treat with hot water chances of skin burn occurs.

Comments are closed.